Duchenne Muscular Dystrophy in Qatar
How patients in Qatar access treatment for duchenne muscular dystrophy via Named Patient Program.
About Duchenne Muscular Dystrophy
Neuromuscular
Treatment access in Qatar
Qatar's MoPH permits unregistered drug import under a named-patient pathway with physician and MoPH approval; Hamad Medical Corp frequently sponsors.
For patients in Qatar with duchenne muscular dystrophy whose required therapy is not locally registered, a Named Patient Program pathway typically applies.
How Reserve Meds supports patients with duchenne muscular dystrophy in Qatar
- Patient or physician contacts us with disease details and therapy requested.
- We verify eligibility in Qatar and confirm US supply.
- Treating physician in Qatar issues prescription and justification.
- We file Qatar-specific NPP/personal-import paperwork.
- We source the drug from a DSCSA-compliant US specialty wholesaler.
- Cold-chain shipment to the patient's physician or hospital pharmacy in Qatar.
Patient support throughout
- Case manager from request through delivery.
- Documentation translation where needed.
- Physician-to-physician support for clinical justification.
- Re-supply coordination for chronic therapy.